Third, studies on fetuin-A and fetuin-B concentrations between NAFLD patients and the controls showed high heterogeneity, which is not surprising given the large differences with respect to the study area and study population. The gene discussed is FETUB; the disease is metabolic dysfunction-associated steatotic liver disease.